Back to search
Lichen Plano-Pilaris
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lichen Plano-Pilaris trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Lichen Plano-Pilaris trials you may qualify forThis study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
Lichen planopilaris (LPP) is a primary lymphocytic cicatricial alopecia characterized by progressive, permanent hair loss and scalp symptoms such as pruritus an…
Rationale Lichen planopilaris (LPP) is a prevalent form of cicatricial alopecia, predominantly affecting women and causing irreversible hair loss. Hydroxychloro…
Lichen planus (LP) is a common immune-mediated skin disease with a prevalence of 1-2% in the general population. It can present with a broad spectrum of clinica…
This study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adults with lichen planopilaris (LPP) or ce…